Searched for
OLANZAPINE
Govt plans crackdown on lookalike drug brandsAccording to people in the know, the government is likely to consider as valid only the brand names which were approved first by the regula...- Look-alike, sounding similar drugs likely to face strict actionEarlier, in January India's Drug Technical Advisory Board (DTAB), India's apex drug advisory body, deliberated on the issue of same brand n...
- Macleods Pharmaceuticals recalls products in US for manufacturing issuesThe company had produced the affected lot at its Baddi plant and later marketed in the US market by Macleods Pharma USA Inc.
- USFDA issues import alert on Jubilant Pharmova's Roorkee plantThe US Food and Drug Administration (USFDA) has taken the action after conducting an inspection of the formulations plant in March this yea...
- Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drugIn a BSE filing, Indoco Remedies announced receipt of approval for its abbreviated new drug application (ANDA) for Olanzapine Tablets USP i...
- No Chinese supply threat for drug companies, but scaling Great Wall is tough“The concerns over supply of Chinese raw material proved to be ill-founded,” Nilesh Gupta, managing director of Lupin, told ET.
- Chinese strategy: Dr Reddy's outsources part manufacturing to local partiesThe company which won the tender to market Olanzapine drug in China, is expected to launch it beginning next year, the official said. The p...
- Chinese growth shot’s some years away for pharma companiesFor most Indian pharmaceutical cos venturing into China, market is still restricted to licensing of speciality products & monetisation may ...
- Zydus Cadila gets USFDA nod to market 4 generic productsPharma firm Zydus Cadila today said it has received final approvals from the US health regulator to market four generic products in America.
- Dr Reddy's, Aurobindo recall drugs from US marketAccording to FDA, "Class-III" classification which was described as "a situation in which use of or exposure to a violative product is not ...
- Torrent recalls anti-psychotic tablet from US marketTorrent Pharma Inc, a US subsidiary of Ahmedabad-based Torrent Pharma is recalling anti-psychotic drug Olanzapine 10 mg tablets from the US...
- Dr Reddy's Laboratories Q4 net up 67% at Rs 571 croreDr Reddy's Laboratories today reported a 66.58 per cent rise in its net profit to Rs 570.89 crore for the quarter ended March 31, 2013.
- Why does Dr Reddys labs commands much lower valuations than other pharma companies?The Hyderabad-based drug company has witnessed volatility in its performance on account of variety of reasons like periodical drug exclusiv...
- Jubilant Life's four medicines get USFDA approvalJubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.
- Sun Pharma gets USFDA nod for generic schizophrenia tabletsSun Pharmaceutical Industries said it has received approval from the US health regulator for its generic Zyprexa Zydis tablets in the Ameri...
- Dr Reddy's Labs: US, domestic business growth augurs wellA limited period generic launch helped drug maker Dr Reddy's Labs post exceptional growth in its US business and boosted its overall perfor...
- Schizophrenia pill Olanzapine, weak rupee drive Dr Reddy's Lab topline to Rs 2,770 croreDr Reddy’s Laboratories’ revenues in the December quarter jumped to Rs 2,770 crore, buoyed by the launch of a star performing drug and a we...
- Surya Pharma launches neuropsychiatric divisionThe Rs 1,600-crore Surya Pharmaceutical has launched its Super speciality Neuropsychiatric division called ALVIN .
- Dr Reddy's expects North American biz to drive growth this FYDr Reddy's Laboratories expects generics business in North America to be its main growth driver this fiscal.
- Ranbaxy Laboratories launches generic Olanzapine tablets in SpainRanbaxy has received necessary regulatory approvals from the Spanish health authorities to manufacture and market Olanzapine in Spain.
Load More
